Zobrazeno 1 - 3
of 3
pro vyhledávání: ''
Autor:
Gideon M. Blumenthal, Haiyan Chen, Nicholas C. Richardson, Yvette L. Kasamon, Jingjing Ye, Ann T. Farrell, Richard Pazdur, R. Angelo de Claro
Publikováno v:
The Oncologist
This article summarizes the clinical review and basis of approval of brentuximab vedotin in combination with cyclophosphamide, doxorubicin, and prednisone as a first‐line regimen for patients with CD30‐expressing peripheral T‐cell lymphoma.
Autor:
Kirsten B. Goldberg, Richard Pazdur, Lei Nie, Jonathon Vallejo, Donna Przepiorka, E. Dianne Pulte, Ann T. Farrell, Amy E. McKee
Publikováno v:
The Oncologist
In 2017, the Food and Drug Administration granted accelerated approval of blinatumomab for the treatment of relapsed or refractory precursor B‐cell acute lymphoblastic leukemia. This article focuses on evidence to support conversion from accelerate
Autor:
Vincenzo Barnaba, Silvia Piconese, Daniele Accapezzato, Eliana M. Coccia, Giancarlo Labbadia, Gabriella d'Ettorre, Eugenio Nelson Cavallari, Fabiana Rizzo, Vincenzo Vullo, Eleonora Timperi, Martina Severa, Ilenia Pacella, Carmela Martire, Ludovica Calvo
Type I IFNs are pleiotropic cytokines that exert concerted activities in the development of antiviral responses. Regulatory T cells represent a physiologic checkpoint in the balance between immunity and tolerance, requiring fine and rapid controls. H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cf6ba8918bb31d39a2a12660893a594
http://hdl.handle.net/11573/868412
http://hdl.handle.net/11573/868412